(Q33998647)

30 July 2017

1 reference

title

Apolipoprotein E gene promoter polymorphisms in Alzheimer's disease (English)

1 reference

30 July 2017

0 references

Bullido MJ

1

1 reference

30 July 2017

Valdivieso F

series ordinal

2

1 reference

30 July 2017

publication date

1 August 2000

1 reference

Microscopy Research and Technique

30 July 2017

published in

1 reference

30 July 2017

volume

50

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

261-267

1 reference

The -491A/T polymorphism of the Apolipoprotein E gene is associated with the ApoEepsilon4 allele and Alzheimer's disease

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Two hepatic enhancers, HCR.1 and HCR.2, coordinate the liver expression of the entire human apolipoprotein E/C-I/C-IV/C-II gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

APOE-491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

The role of APOE polymorphisms in late-onset dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

In vivo footprinting analysis of the hepatic control region of the human apolipoprotein E/C-I/C-IV/C-II gene locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Tumor necrosis factor-alpha modulates monocyte/macrophage apoprotein E gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Degradation of macrophage ApoE in a nonlysosomal compartment. Regulation by sterols

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Lack of allelic imbalance in APOE epsilon3/4 brain mRNA expression in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Progress toward valid transgenic mouse models for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Characterization of an Upstream Regulatory Element of the Human Apolipoprotein E Gene, and Purification of Its Binding Protein from the Human Placenta1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Distortion of allelic expression of apolipoprotein E in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Apolipoprotein E and the CNS response to injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Alterations in apolipoprotein E expression during aging and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Hormonal regulation of human apolipoprotein E gene expression in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Evidence for the role of the secretory pattern of growth hormone in the regulation of serum concentrations of cholesterol and apolipoprotein E in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Nucleotide sequence and structure of the human apolipoprotein E gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Alzheimer's disease: genetic studies and transgenic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

The -491 A/T polymorphism in the regulatory region of the apolipoprotein E gene and early-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Cis-acting human ApoE tissue expression element is associated with human pattern of intraneuronal ApoE in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Biphasic effects of estrogen on apolipoprotein synthesis in human hepatoma cells: mechanism of antagonism by testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: risk factors for Alzheimer's dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Apolipoprotein E promoter polymorphism and sporadic Alzheimer's disease in a Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Specific regional transcription of apolipoprotein E in human brain neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations--the ECTIM Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820000815%2950%3A4%3C261%3A%3AAID-JEMT2%3E3.0.CO%3B2-B

10.1002/1097-0029(20000815)50:4<261::AID-JEMT2>3.0.CO;2-B

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference